McCoy, Karen S.

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR

Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., et al. (2015) · New England Journal of Medicine

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 1,622

Pulmonary hypertension in cystic fibrosis with advanced lung disease

Hayes, D., Tobias, J. D., Mansour, H. M., Kirkby, S., McCoy, K. S., Daniels, C. J., & Whitson, B. A. (2014) · American Journal of Respiratory and Critical Care Medicine

Pulmonary Hypertension Research and TreatmentsCystic Fibrosis Research Advances

Cited by 77

Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study

Flume, P. A., Biner, R. F., Downey, D. G., Brown, C., Jain, M., Fischer, R., De Boeck, K., Sawicki, G. S., Chang, P., Paz-Diaz, H., et al. (2021) · The Lancet Respiratory Medicine

Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery

Cited by 52

Impact of pulmonary hypertension on survival in patients with cystic fibrosis undergoing lung transplantation: an analysis of the UNOS registry

Hayes, D., Higgins, R. S., Kirkby, S., McCoy, K. S., Wehr, A. M., Lehman, A. M., & Whitson, B. A. (2014) · Journal of Cystic Fibrosis

Transplantation: Methods and OutcomesPulmonary Hypertension Research and Treatments

Cited by 35

Pulmonary artery pressure and benefit of lung transplantation in adult cystic fibrosis patients

Hayes, D., Tumin, D., Daniels, C. J., McCoy, K. S., Mansour, H. M., Tobias, J. D., & Kirkby, S. E. (2016) · The Annals of Thoracic Surgery

Transplantation: Methods and OutcomesPulmonary Hypertension Research and Treatments

Cited by 16